Dr. Marcelo V. Bendix, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Years since graduation
- 41
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 130
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
FL license ME0055830 -
Internal Medicine Physician
FL license ME0055830
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Endocrinology Specialists of South Florida, Inc (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 130
- Services billed
- 308
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 206 | 109 |
| Established patient office or other outpatient visit, 20-29 minutes | 36 | 26 |
| Ultrasound scan of head and neck soft tissue | 17 | 16 |
| New patient office or other outpatient visit, 45-59 minutes | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Miami, FL | 1,347 |
| Ozempic (semaglutide) Other prescribers in Miami, FL | 1,066 |
| Soliqua 100-33 (insulin glargine/lixisenatide) Other prescribers in Miami, FL | 669 |
| Synthroid (levothyroxine sodium) Other prescribers in Miami, FL | 513 |
| Glipizide-Metformin (glipizide/metformin hcl) | 449 |
| Mounjaro (tirzepatide) Other prescribers in Miami, FL | 423 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) (insulin pump cart,auto,bt,g6/7) | 405 |
| Jardiance (empagliflozin) Other prescribers in Miami, FL | 331 |
| Metformin Hcl Other prescribers in Miami, FL | 330 |
| Novolog (insulin aspart) Other prescribers in Miami, FL | 291 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 130 payments worth $2,745 in total to this clinician.
| Insulet Corporation | $1,249 |
|---|---|
| Novo Nordisk Inc | $672 |
| Dexcom, Inc. | $237 |
| Lilly USA, LLC | $169 |
| Tandem Diabetes Care, Inc. | $90.83 |
| Xeris Pharmaceuticals, Inc. | $69.99 |
| AbbVie Inc. | $56.29 |
| Corcept Therapeutics | $48.08 |
| Food and Beverage | $2,745 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.